Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...
Drop by the 880 CHED studios at 84th Street and Roper Road from 7 a.m. to 11 a.m. and meet some of your favourite 880 staff, get your hands on swag and enter for prizes. 630 CHED, the best talk radio ...
Editor’s note: This is the second part in a series about Plumas County’s unsolved infamous Keddie murders. Some readers might find the following information unsettling or objectionable. Was the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback